首页> 美国卫生研究院文献>Medicines >Screening of Crude Drugs Used in Japanese Kampo Formulas for Autophagy-Mediated Cell Survival of the Human Hepatocellular Carcinoma Cell Line
【2h】

Screening of Crude Drugs Used in Japanese Kampo Formulas for Autophagy-Mediated Cell Survival of the Human Hepatocellular Carcinoma Cell Line

机译:日本汉方配方中用于自噬介导的人类肝癌细胞系细胞存活的原料药的筛选

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Autophagy is a catabolic process through which dysfunctional proteins and organelles are degraded, and that is associated with the proliferation of cancer cells. The aim of this study was to screen approximately 130 kinds of crude drugs used in Japanese Kampo formulas to identify crude drugs that would regulate the proliferation through autophagy of human hepatocellular carcinoma HepG2 cells. >Methods: Extracts of each crude drug were prepared using methanol. Protein levels were determined using Western blotting. Cell viability was measured by MTT assay. >Results: Among the 130 crude extracts, 24 of them increased LC3-II expression. Among these, Goboshi (burdock fruit), Soboku (sappan wood), Mokko (saussurea root), Rengyo (forsythia fruit), and Hikai (dioscorea) notably suppressed the proliferation of HepG2 cells and increased p62 expression levels, which suggested that these five extracts downregulate the autophagic activity resulting in the accumulation of p62. On the other hand, Hishinomi (water chestnut), Biwayo (loquat leaf), and Binroji (areca) induced cell growth and decreased or were uninvolved with p62 expression levels, which implied that these three extracts might induce autophagy modulators for cell growth. >Conclusions: The results suggest that the compounds contained in the crude drugs selected for this study could control cell viability by regulating autophagic activity in HepG2 cells. The isolation and identification of the active compounds in these drugs might lead to the development of agents for autophagy research and cancer chemoprevention.
机译:>背景:自噬是一种分解代谢过程,通过该过程,功能失调的蛋白质和细胞器被降解,并与癌细胞的增殖有关。这项研究的目的是筛选日本Kampo配方中使用的约130种粗药物,以鉴定可通过人类肝细胞癌HepG2细胞自噬调节增殖的粗药物。 >方法:每种原料药的提取物均使用甲醇制备。使用蛋白质印迹法测定蛋白质水平。细胞存活力通过MTT测定法测量。 >结果:在130种粗提取物中,其中24种增加了LC3-II的表达。其中,Goboshi(牛bur果),Soboku(s木),Mokko(雪莲根),Rengyo(连翘果)和Hikai(dioscorea)显着抑制了HepG2细胞的增殖并增加了p62的表达水平,这表明这五个提取物下调自噬活性,导致p62积累。另一方面,Hishinomi(water),Biwayo(lo叶)和Binroji(槟榔)诱导细胞生长,并降低或不参与p62表达水平,这暗示这三种提取物可能诱导细胞生长的自噬调节剂。 >结论:结果表明,本研究所选的粗制药物中包含的化合物可以通过调节HepG2细胞的自噬活性来控制细胞活力。这些药物中活性化合物的分离和鉴定可能会导致自噬研究和癌症化学预防药物的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号